Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)
Komen for the Cure named Gail Marcus as chief financial officer, GaryDicovitsky as vice president of development and Martina "Tina" Hone as vicepresident of public policy. Hone also will serve as president of the Susan G.Komen for the Cure Advocacy Alliance, Komen's sister advocacy organization.All three will report directly to Susan G. Komen for the Cure President andCEO Hala Moddelmog.
Advertisement
"The addition of these excellent leaders underscores Komen's commitment tosecure better health care for everyone and to ensure there are adequatedollars to fund our mission to end breast cancer forever," said Moddelmog."Gail, Gary and Tina will add depth to our already outstanding finance,development and public policy teams."
These additions also cement the Dallas-based organization's nationalpresence: Hone will be based out of a new Washington, D.C. office, to beopened early next year, and Dicovitsky will be based on the West Coast.
Marcus will oversee all financial matters affecting the organization,which has received Charity Navigator's highest rating -- four stars -- for thepast two consecutive years (FY 2006 and FY 2007). The organization recentlyannounced its 2008 research grant portfolio -- investing an unprecedented $100million in research grants to U.S. and international scientists this yearalone.
"Susan G. Komen for the Cure already excels in managing its finances anddonations," said Marcus. "We will continue to be responsible stewards of fundsas we strive to invest an additional $2 billion over the next ten years towardfulfilling our promise to end breast cancer forever."
Marcus' career has been marked by significant leadership positions indomestic and global healthcare. Prior to joining Komen, Marcus was Presidentand CEO of Caris Diagnostics. A breast cancer survivor, she previously heldsenior leadership roles with AdvancePCS, United HealthGroup and CignaCorporation.
She earned her M.B.A. from the Wharton Graduate Division of the Universityof Pennsylvania, a M.S.E. from the University of Pennsylvania's Moore Schoolof Engineering and a B.A. from Wesleyan University. She has been serving onthe board of directors for the Susan G. Komen for the Cure Dallas Affiliate.
Dicovitsky will oversee the cultivation of major gifts, planned gifts,foundation gifts, individual philanthropic gifts, direct marketing ande-philanthropy to advance Komen's promise to raise and invest an additional $2billion over the next decade to breast cancer research and community programs.Since inception, Komen has invested more than $1.2 billion in the cause,making it the world's largest source of private funds for breast cancerresearch and community outreach programs.
"Susan G. Komen for the Cure is unparalleled in its commitment andambition," said Dicovitsky. "Leveraging the passion of its millions of globalsupporters, I have no doubt Komen can achieve its goal of investing another $2billion in the effort to discover and deliver the cures."
Dicovitsky's background spans more than two decades in philanthropicfundraising at some of the nation's leading universities, including DartmouthCollege, Princeton University, Pomona College and the University of Virginia.He most recently served as the Vice President for Development and AlumniRelations at the California Institute of Technology, where he led the largestfundraising initiative in Caltech's history, exceeding its goal by raising$1.424 billion. Considering Caltech's relatively small alumni base, facultyand staff, this ranks among the most successful of all university fundraisingcampaigns in history. He earned a Masters of Education from Loyola College,and a B.A. from Dartmouth College.
Hone will serve as the leader of Komen's Washington, D.C. office,including serving as a central liaison to the White House, Capitol Hill, statelegislatures, and key policymakers. Under her leadership, the 501c4 Susan G.Komen Advocacy Alliance will continue to aggressively advocate at all levelsof government for increased funding for research and access to screening andtreatment.
"Komen is known in Washington as the face and voice of women and survivorsacross the country," said Hone. "In the coming months, we plan to dramaticallystrengthen the Susan G. Komen Advocacy Alliance's position as a positive agentof change from the White House to each state house."
Hone has broad experience in public policy, coming to Komen most recentlyfrom Congressional Quarterly, where she was the Executive Director of CQEvents. Prior to joining CQ, she served as the Vice President for PublicAffairs and Government Relations at the American Legacy Foundation. She alsois a former House Judiciary Committee Counsel and a former AssociateUndersecretary at the U.S. Department of Commerce. Hone received her lawdegree from the University of California, Berkeley (Boalt Hall) and her B.A.in political science from the University of Chicago.
Marcus replaces outgoing CFO, Kevin Speirits, who remained with theorganization through a period of transition after resigning earlier this year.Hone replaces Diane Balma, who previously served in this role beforetransitioning earlier this year to Komen's vice president of strategicalliances.
About Susan G. Komen for the Cure
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would doeverything in her power to end breast cancer forever. In 1982, that promisebecame Susan G. Komen for the Cure(R) and launched the global breast cancermovement. Today, Komen for the Cure is the world's largest grassroots networkof breast cancer survivors and activists fighting to save lives, empowerpeople, ensure quality care for all and energize science to find the cures.Thanks to events like the Susan G. Komen Race for the Cure, we have investedmore than $1.2 billion to fulfill our promise, becoming the largest source ofnonprofit funds dedicated to the fight against breast cancer in the world. Formore information about Susan G. Komen for the Cure, breast health or breastcancer, visit http://www.komen.org or call 1-800 I'M AWARE.
SOURCE Susan G. Komen for the Cure
